Clinical trial
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate…
NCT00091390 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00091390 |
|---|---|
| Title | Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer |
| Official title | Phase II Trial Of Combined High Dose Rate Brachytherapy And External Beam Radiotherapy For Adenocarcinoma Of The Prostate |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH NRG Oncology |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Radiation |
| Interventions | High Dose brachytherapy boost, External beam radiotherapy |
| Enrollment | 129 |
| Start date | Jul 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Dec 1, 2016 |
| First posted | Sep 9, 2004 |
| Last update posted | Aug 10, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: